A growing body of research has shown that lncRNA PVT1 has different degrees of abnormal expression in gynaecological malignancies and may affect a variety of tumour cell regulatory processes, which are closely related to the occurrence and progression of tumours. This evidence concerns the gene PVT1 and neoplasm.